Literature DB >> 2292644

Classifications of radiopaque lesions of the tendo Achillis.

K L Morris1, J A Giacopelli, D Granoff.   

Abstract

The authors present an anatomically-based classification to identify radiopaque lesions of the tendo Achillis. Numerous etiologic and pathologic processes are responsible for the formation of radiopaque lesions found in this tendon. The anatomical location and morphologic appearance of the lesions are represented in this classification system to better acquaint the physician with reported etiologic causes. Treatment based upon classification sites are discussed to complete this historical presentation.

Mesh:

Year:  1990        PMID: 2292644

Source DB:  PubMed          Journal:  J Foot Surg        ISSN: 0449-2544


  6 in total

1.  Successful non-operative management of an Achilles fracture.

Authors:  F S Haddad; P Ting; N J Goddard
Journal:  J R Soc Med       Date:  1999-02       Impact factor: 5.344

2.  A silent massive ossification of Achilles tendon as a suspected rare late effect of surgery for club foot.

Authors:  Francesco Manfreda; Paolo Ceccarini; Marco Corzani; Rosario Petruccelli; Pierluigi Antinolfi; Giuseppe Rinonapoli; Auro Caraffa
Journal:  SAGE Open Med Case Rep       Date:  2018-05-14

3.  Heterotopic Ossification of Tendo Achilles: An Uncommon Clinical Entity.

Authors:  Raju Vaishya; Celestine O Maduka; Amit Kumar Agarwal; Vipul Vijay; Abhishek Vaish
Journal:  J Orthop Case Rep       Date:  2019

4.  Could ossification of the achilles tendon have a hereditary component?

Authors:  Chawki Cortbaoui; Jihad Matta; Rayan Elkattah
Journal:  Case Rep Orthop       Date:  2013-04-30

5.  Ossification of the bilateral Achilles tendon: a rare entity.

Authors:  Abhishek J Arora; Richa Arora
Journal:  Acta Radiol Open       Date:  2015-09-08

6.  Imaging Features of Soft-Tissue Calcifications and Related Diseases: A Systematic Approach.

Authors:  Zhen-An Hwang; Kyung Jin Suh; Dillon Chen; Wing P Chan; Jim S Wu
Journal:  Korean J Radiol       Date:  2018-10-18       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.